机译:Neoadjuvant设置中乳腺癌患者PDL1蛋白表达的预测性和预测值
Shanghai Jiao Tong Univ Sch Med Renji Hosp Dept Breast Surg 160 Pujian Rd Shanghai 200127;
Shanghai Jiao Tong Univ Sch Med Renji Hosp Dept Breast Surg 160 Pujian Rd Shanghai 200127;
Shanghai Jiao Tong Univ Sch Med Renji Hosp Dept Breast Surg 160 Pujian Rd Shanghai 200127;
Shanghai Jiao Tong Univ Sch Med Renji Hosp Dept Breast Surg 160 Pujian Rd Shanghai 200127;
Shanghai Jiao Tong Univ Sch Med Renji Hosp Dept Breast Surg 160 Pujian Rd Shanghai 200127;
Shanghai Jiao Tong Univ Sch Med Renji Hosp Dept Breast Surg 160 Pujian Rd Shanghai 200127;
Shanghai Jiao Tong Univ Sch Med Renji Hosp Dept Breast Surg 160 Pujian Rd Shanghai 200127;
Shanghai Jiao Tong Univ Sch Med Renji Hosp Dept Breast Surg 160 Pujian Rd Shanghai 200127;
Shanghai Jiao Tong Univ Sch Med Renji Hosp Dept Breast Surg 160 Pujian Rd Shanghai 200127;
Shanghai Jiao Tong Univ Sch Med Renji Hosp Dept Breast Surg 160 Pujian Rd Shanghai 200127;
Breast cancer; neoadjuvant; PDL1; predictive; prognostic;
机译:Neoadjuvant设置中乳腺癌患者PDL1蛋白表达的预测性和预测值
机译:乳腺癌新辅助化疗后Mucin-1蛋白和mRNA表达作为预后和预测指标的评估
机译:基于蒽环类新辅助化疗治疗埃及患者局部晚期乳腺癌中拓扑异构酶Hoc和金属蛋白酶1表达的组织抑制剂的预测和预后作用。
机译:Cox-2和VEGF在接受新辅助化疗的乳腺癌患者中的预后意义
机译:转移相关基因的遗传变异和蛋白质表达是乳腺癌患者肿瘤侵袭性,复发和生存的标志。
机译:PDL1蛋白表达在新辅助乳腺癌患者中的预测和预后价值
机译:乳腺癌患者Zeb1蛋白表达的预测性和预测值Neoadjuvant化疗